ZA882269B - Immunogenic recombinant yeast expression product and method for purifying it - Google Patents

Immunogenic recombinant yeast expression product and method for purifying it

Info

Publication number
ZA882269B
ZA882269B ZA882269A ZA882269A ZA882269B ZA 882269 B ZA882269 B ZA 882269B ZA 882269 A ZA882269 A ZA 882269A ZA 882269 A ZA882269 A ZA 882269A ZA 882269 B ZA882269 B ZA 882269B
Authority
ZA
South Africa
Prior art keywords
purifying
recombinant yeast
expression product
yeast expression
immunogenic recombinant
Prior art date
Application number
ZA882269A
Other languages
English (en)
Inventor
Nussenzweig Victor
J. Barr Philip
Original Assignee
New York University
Chiron Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University, Chiron Corporation filed Critical New York University
Publication of ZA882269B publication Critical patent/ZA882269B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
ZA882269A 1987-03-30 1988-03-30 Immunogenic recombinant yeast expression product and method for purifying it ZA882269B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/032,327 US4826957A (en) 1985-07-12 1987-03-30 Immunogenic recombinant yeast expression product and method for purifying it

Publications (1)

Publication Number Publication Date
ZA882269B true ZA882269B (en) 1988-09-22

Family

ID=21864347

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882269A ZA882269B (en) 1987-03-30 1988-03-30 Immunogenic recombinant yeast expression product and method for purifying it

Country Status (14)

Country Link
US (1) US4826957A (ja)
EP (1) EP0307472B1 (ja)
JP (1) JPH01503517A (ja)
AT (1) ATE81136T1 (ja)
AU (1) AU615451B2 (ja)
DE (1) DE3875043T2 (ja)
DK (1) DK665688A (ja)
ES (1) ES2009588A6 (ja)
HK (1) HK112693A (ja)
IL (1) IL85906A0 (ja)
NZ (1) NZ224088A (ja)
PH (1) PH27079A (ja)
WO (1) WO1988007550A1 (ja)
ZA (1) ZA882269B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229829B1 (en) * 1985-07-12 1995-02-22 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US4997647A (en) * 1987-03-30 1991-03-05 New York University Vaccine against the sporozoite stage of malaria
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
US5853739A (en) * 1988-05-02 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Transmission-blocking vaccine against malaria
GB8812214D0 (en) * 1988-05-24 1988-06-29 Hoffmann La Roche Use of peptide from circumsporozoite protein of p falciparum as universally recognized t-cell epitope
AU7744491A (en) * 1990-04-16 1991-11-11 Strohtech, Inc. Expression of recombinant hemoglobin in yeast
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
WO1992014486A1 (en) 1991-02-22 1992-09-03 THE UNITED STATES OF AMERICA as represented by THE SECRETARY, THE U.S. DEPARTMENT OF COMMERCE Transmission blocking vaccine against malaria
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)
JP2002537102A (ja) 1999-02-26 2002-11-05 カイロン コーポレイション 吸着された高分子および微粒子を有するミクロエマルジョン
US6737262B1 (en) * 2000-07-11 2004-05-18 Robert I. Bolla Animal feed containing polypeptides
AU2006214694B2 (en) 2005-01-18 2011-09-08 Walter Reed Army Institute Of Research A plasmodium vivax hybrid circumsporozoite protein and vaccine
MX2009000650A (es) * 2006-07-18 2009-07-02 Secretary Of The Army The Unit Vacunas para malaria.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
ATE70308T1 (de) * 1984-09-12 1991-12-15 Chiron Corp Hybridpartikel-immunogene.
EP0229829B1 (en) * 1985-07-12 1995-02-22 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it

Also Published As

Publication number Publication date
DK665688A (da) 1989-01-30
EP0307472B1 (en) 1992-09-30
HK112693A (en) 1993-10-29
EP0307472A4 (en) 1989-06-27
AU1791488A (en) 1988-11-02
DK665688D0 (da) 1988-11-29
DE3875043T2 (de) 1993-02-25
IL85906A0 (en) 1988-09-30
ES2009588A6 (es) 1989-10-01
US4826957A (en) 1989-05-02
JPH01503517A (ja) 1989-11-30
EP0307472A1 (en) 1989-03-22
ATE81136T1 (de) 1992-10-15
PH27079A (en) 1993-02-01
DE3875043D1 (de) 1992-11-05
AU615451B2 (en) 1991-10-03
WO1988007550A1 (en) 1988-10-06
NZ224088A (en) 1990-12-21

Similar Documents

Publication Publication Date Title
HUT52963A (en) Process for production of recombinant coccidiose vaccines
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
AU575588B2 (en) Extraction of human-y interferon of 18 kdalton using the protease inhibitor guanidine-hcp
GB8721424D0 (en) Recombinant expression method
AU577314B2 (en) Human y interferon fragment and production from recombinant microbes
AU2789189A (en) The improved method of creating inflatable products
ZA882269B (en) Immunogenic recombinant yeast expression product and method for purifying it
HU9501288D0 (en) Recombinant method and host for manufacture of xylitol
AU580348B2 (en) A process for the cleavage of peptides and proteins at the methionyl bond
AU5941486A (en) Tetanus vaccine from cloned antigen
HUT43111A (en) Process for producing human lizozime
GB9010552D0 (en) Method for the recombinant production of hirudins and novel hirudins
AU1092588A (en) Expression of the p. falciparum circumsporozoite protein by yeast
IL85905A0 (en) Immunogenic recombinant yeast expression product and method for purifying it
IL94526A0 (en) Method for c-terminal modification of proteins
AU590712B2 (en) Immune interferon and method for its purification
GR880100195A (en) Immunogenic recombinant yeast expression product and method for purifying it
GR3018066T3 (en) Schizosaccharomyces specific polypeptide.